|
| 36765916 | Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection. | Cancers (Basel) | 2023 |
| 36804443 | IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study. | Urology | 2023 |
| 36868922 | Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. | Eur Urol Oncol | 2023 |
| 36828362 | ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins. | Mod Pathol | 2023 |
| 34593984 | Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. | Prostate Cancer Prostatic Dis | 2022 |
| 35478055 | Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer. | Med Oncol | 2022 |
| 35840465 | Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study. | Urol Oncol | 2022 |
| 36349916 | Reply by Authors. | J Urol | 2022 |
| 36050450 | Urinary marker panels for aggressive prostate cancer detection. | Sci Rep | 2022 |
| 36006048 | Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy. | J Urol | 2022 |
| 34433304 | Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. | J Urol | 2022 |
| 32929627 | A prospective comparative study of routine versus deferred pelvic drain placement after radical prostatectomy: impact on complications and opioid use. | World J Urol | 2021 |
| 33623103 | Advances in the selection of patients with prostate cancer for active surveillance. | Nat Rev Urol | 2021 |
| 33596212 | Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer. | PLoS One | 2021 |
| 33487007 | Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance. | J Urol | 2021 |
| 33541309 | A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance. | BMC Urol | 2021 |
| 33530745 | Effect of Erythropoietin on Erectile Function after Radical Prostatectomy: The ERECT Randomized Clinical Trial. | J Urol | 2021 |
| 34106707 | Development of Parallel Reaction Monitoring Assays for the Detection of Aggressive Prostate Cancer Using Urinary Glycoproteins. | J Proteome Res | 2021 |
| 34086480 | Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death. | J Clin Oncol | 2021 |
| 33227307 | Contemporary Assessment of the Most Cited Clinical, Basic Science, and Guidelines Papers in Urology: A Reference for Urology Journal Club. | Urology | 2021 |
| 32654363 | Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial. | BJU Int | 2021 |
| 32820256 | A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridization. | Prostate Cancer Prostatic Dis | 2021 |
| 32444264 | Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. | Eur Urol | 2020 |
| 32065862 | Assessment of high-grade prostate cancer risk using prostate cancer biomarkers. | Can J Urol | 2020 |
| 32039537 | Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance. | BJU Int | 2020 |
| 33204318 | Urinary glycoproteins associated with aggressive prostate cancer. | Theranostics | 2020 |
| 29626845 | Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit. | BJU Int | 2019 |
| 31930191 | Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and <i>in vitro</i> studies of prostate cancer. | J Transl Autoimmun | 2019 |
| 31530439 | PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. | Clin Genitourin Cancer | 2019 |
| 30810464 | Clinical Validation of IsoPSAâ¿¢, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate Cancer. | J Urol | 2019 |
| 30925030 | In Reply. | Stem Cells Transl Med | 2019 |
| 30735000 | A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. | Stem Cells Transl Med | 2019 |
| 30570825 | Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer. | BJU Int | 2019 |
| 28736318 | Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study. | J Urol | 2018 |
| 33636944 | High "phi"ve. | J Appl Lab Med | 2018 |
| 30237023 | A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy. | Eur Urol | 2018 |
| 30288147 | Best of the 2018 AUA Annual Meeting. | Rev Urol | 2018 |
| 29673946 | Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy. | J Urol | 2018 |
| 29409845 | Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System. | Urology | 2018 |
| 29232037 | Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer. | BJU Int | 2018 |
| 28797714 | Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer. | J Urol | 2018 |
| 27367645 | Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era. | BJU Int | 2017 |
| 28232176 | Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk Men. | Urology | 2017 |
| 28147335 | Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients. | Oncotarget | 2017 |
| 28117387 | Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice. | Prostate Cancer Prostatic Dis | 2017 |
| 29541580 | Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation. | Urol Case Rep | 2017 |
| 29302240 | Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA. | Rev Urol | 2017 |
| 29262631 | Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy. | Oncotarget | 2017 |
| 28786124 | Risk factors for metastatic prostate cancer: A sentinel event case series. | Prostate | 2017 |
| 28520829 | Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. | JAMA Oncol | 2017 |